Nedzlek Christopher, Blanchett Jacob, Illg Zachary, DiGiacinto Geoffrey, Cunningham Kathryn, Wisniewski Samuel J, Tuttle Jacob
Department of Emergency Medicine Henry Ford Wyandotte Hospital, Wyandotte, MI, USA.
College of Osteopathic Medicine Statewide Campus System, East Lansing, MI, USA Michigan State University.
Spartan Med Res J. 2024 Sep 10;9(3):124542. doi: 10.51894/001c.124542. eCollection 2024.
COPD is a progressive lung disease with marked airflow limitation. It has a large global prevalence and is managed with antibiotics, bronchodilators, and corticosteroids. Despite the prevalence, corticosteroid prescribing regimens differ widely amongst providers. This study aims to evaluate baseline corticosteroid prescribing patterns, the ability to change corticosteroid prescribing patterns with the utilization of an educational initiative, and to evaluate the effect of corticosteroid dose on length of stay, 30-day hospital readmission, mortality, and total hospital insulin dosing.
This study was conducted via a retrospective observational study. Providers at a single institution answered a baseline questionnaire on COPD corticosteroid prescribing patterns and subsequently received an educational presentation regarding evidence-based corticosteroid recommendations. Data were then retrospectively obtained and analyzed evaluating corticosteroid prescribing patterns both pre- and post-educational intervention. Data were analyzed using IBM SPSS Version 25.
The provider survey revealed that most (95.3%) administered 125 mg of methylprednisolone to patients treated for AECOPD. The most common reason a particular dose of corticosteroid was administered was due to previous teaching or practice patterns. The mean initial steroid dose of methylprednisolone decreased following the educational initiative from 114.24 mg to 72.8 mg (p < 0.01). This corresponded to a 69% (n=41) decrease of providers using 125 mg methylprednisolone (p < 0.01), and increased prescribing of 62.5 mg methylprednisolone by 42.6% (n=66). The mean LOS following hospital admission for AECOPD in the pre-intervention group was 5.80 days, while the mean LOS following the targeted educational intervention decreased to 4.82 days (p = 0.01).
The implementation of an educational intervention may change provider corticosteroid prescribing patterns. Additionally, lower corticosteroid dose in the Emergency Department may decrease patient length of stay. Keywords: Corticosteroid, COPD, LOS, recommendations, steroid.
慢性阻塞性肺疾病(COPD)是一种具有明显气流受限的进行性肺部疾病。它在全球范围内患病率很高,治疗方法包括使用抗生素、支气管扩张剂和皮质类固醇。尽管患病率很高,但不同医疗服务提供者的皮质类固醇处方方案差异很大。本研究旨在评估皮质类固醇的基线处方模式,利用教育倡议改变皮质类固醇处方模式的能力,并评估皮质类固醇剂量对住院时间、30天内再次入院率、死亡率和医院胰岛素总剂量的影响。
本研究通过回顾性观察研究进行。单一机构的医疗服务提供者回答了一份关于COPD皮质类固醇处方模式的基线问卷,随后接受了一次关于循证皮质类固醇推荐的教育讲座。然后回顾性获取并分析数据,评估教育干预前后的皮质类固醇处方模式。使用IBM SPSS 25版软件进行数据分析。
医疗服务提供者调查显示,大多数(95.3%)在治疗慢性阻塞性肺疾病急性加重期(AECOPD)的患者时给予125毫克甲泼尼龙。给予特定剂量皮质类固醇的最常见原因是以往的教学或实践模式。教育倡议实施后,甲泼尼龙的平均初始类固醇剂量从114.24毫克降至72.8毫克(p < 0.01)。这相当于使用125毫克甲泼尼龙的医疗服务提供者减少了69%(n = 41)(p < 0.01),而62.5毫克甲泼尼龙的处方量增加了42.6%(n = 66)。干预前组AECOPD患者入院后的平均住院时间为5.80天,而针对性教育干预后的平均住院时间降至4.82天(p = 0.01)。
实施教育干预可能会改变医疗服务提供者的皮质类固醇处方模式。此外,急诊科较低的皮质类固醇剂量可能会缩短患者的住院时间。关键词:皮质类固醇;慢性阻塞性肺疾病;住院时间;推荐;类固醇